SEC Filing Summary: GSK Plc Form 6-K
Business Context and Reporting Period
This Form 6-K was filed by GlaxoSmithKline plc on September 4, 2019, for the month of September 2019. The filing serves as a transaction notification regarding a specific insider transaction under the Company's 2009 Share Value Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share award and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely details a single transaction involving the award of ordinary shares to a Person Discharging Managerial Responsibilities (PDMR).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory notification of a share award event.
Key Facts for Investor Verification
- Transaction Type: Award of Ordinary Shares under the 2009 Share Value Plan.
- Recipient: Mrs. V A Whyte, SVP & Company Secretary.
- Volume: 10,050 Ordinary Shares.
- Price: £17.434 per share.
- Date of Transaction: September 3, 2019.
- Instrument: Ordinary shares of 25 pence each (ISIN: GB0009252882).